The E test strip (AB Biodisk, Solna, Sweden) as an antimicrobial susceptibility testing method is a new and promising tool with broad application in microbiology. This method is less labour intensive than broth dilution methods and may be useful for testing individual clinical isolates.In contrast to several publications comparing E test antibacterial strips with NCCLS reference methods, there is little information about the performance of E test antifungal strips. This study compared fluconazole and itraconazole MICs obtained by E test with a microbroth dilution method performed to NCCLS guidelines.Fluconazole and itraconazole E test results exhibited good correlation with the broth microdilution (82% and 81% agreement within +/-1 two-fold...
One hundred thirty yeast clinical isolates comprised of 81 C. albicans , 22 C. tropicalis , 11 C. pa...
The commercial technique Vitek 2 system for antifungal susceptibility testing of yeast species was e...
Fluconazole susceptibility among 800 clinical Candida isolates (60% C. albicans) and two control str...
A comparison of the E test, the broth microdilution test, and the reference broth macrodilution susc...
Trinta Candida albicans isoladas de pacientes portadores de candidose oral e 30 Candida albicans iso...
macrodilution method for antifungal susceptibility testing was compared with the E test by testing 8...
A comparative evaluation of two broth microdilution methods for antifungal susceptibility testing of...
A comparative evaluation of the Etest and the broth microdilution methods for antifungal susceptibil...
Two commercial antifungal susceptibility testing systems (Fungitest and Neo-Sensitabs) were compared...
WOS: 000254066100013PubMed ID: 18343749In response to the recent increase in Aspergillus infections,...
E-test methodology was compared with Clinical and Laboratory Standards Institute (CLSI) broth microd...
Isavuconazole is a new broad-spectrum triazole, with significant in vitro activity against yeasts. I...
Introduction: Clinical and Laboratory Standards (CLSI) Institute recommends CLSI M27-A method as a s...
We compared MIC test strip (MTS) and Sensititre YeastOne (SYO) methods with EUCAST and CLSI methods ...
Antifungal susceptibility testing may be an important aid in the treatment of patients with life-thr...
One hundred thirty yeast clinical isolates comprised of 81 C. albicans , 22 C. tropicalis , 11 C. pa...
The commercial technique Vitek 2 system for antifungal susceptibility testing of yeast species was e...
Fluconazole susceptibility among 800 clinical Candida isolates (60% C. albicans) and two control str...
A comparison of the E test, the broth microdilution test, and the reference broth macrodilution susc...
Trinta Candida albicans isoladas de pacientes portadores de candidose oral e 30 Candida albicans iso...
macrodilution method for antifungal susceptibility testing was compared with the E test by testing 8...
A comparative evaluation of two broth microdilution methods for antifungal susceptibility testing of...
A comparative evaluation of the Etest and the broth microdilution methods for antifungal susceptibil...
Two commercial antifungal susceptibility testing systems (Fungitest and Neo-Sensitabs) were compared...
WOS: 000254066100013PubMed ID: 18343749In response to the recent increase in Aspergillus infections,...
E-test methodology was compared with Clinical and Laboratory Standards Institute (CLSI) broth microd...
Isavuconazole is a new broad-spectrum triazole, with significant in vitro activity against yeasts. I...
Introduction: Clinical and Laboratory Standards (CLSI) Institute recommends CLSI M27-A method as a s...
We compared MIC test strip (MTS) and Sensititre YeastOne (SYO) methods with EUCAST and CLSI methods ...
Antifungal susceptibility testing may be an important aid in the treatment of patients with life-thr...
One hundred thirty yeast clinical isolates comprised of 81 C. albicans , 22 C. tropicalis , 11 C. pa...
The commercial technique Vitek 2 system for antifungal susceptibility testing of yeast species was e...
Fluconazole susceptibility among 800 clinical Candida isolates (60% C. albicans) and two control str...